Mandatory Participants on the Tumor Board
Plastic surgery, dermatology, medical oncology, radiology, radiation oncology and nuclear medicine. If necessary, associated departments are included, for example dermatopathology, institute of tissue medicine and pathology, etc.
Inclusion criteria for patients to be presented
- Patients with malignant melanoma from stage IIC/T4b
- Rare malignant skin tumors regardless of stage (including Merkel cell carcinoma, dermatofibrosarcoma protuberans, malignant fibrous histiocytoma, leiomyosarcoma, Kaposi's sarcoma, angiosarcoma)
- Discussion of all problem cases regardless of stage and tumor entity and/or all patients with interdisciplinary issues and/or changes in therapy that deviate from established treatment paths
- Malignant, epithelial tumors (basal cell carcinoma and spinal cell carcinoma) - i.e. discussion of possible problem cases with interdisciplinary questions; e.g. Complicated localization, expansion/infiltration (e.g.: rodent ulcer, terebranous ulcer), metastatic tumors, immunosuppressed patients
- Patients with newly occurring distant metastasis are discussed in the tumor conference
- Lymphomas are discussed at the lymphoma board. See Lymphoma Board Specification Table
- If the therapy implementation deviates from the original therapy recommendation, information must be provided at the tumor conference. Reasons for changes and new therapy must be documented.
Patient Registration
Registration is done by the referrer using the Registration Form Tumor Board via the Plastic Surgery Secretariat. The patient list will be sent by the Plastic Surgery Secretariat in accordance with the registration deadline.